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Understanding the molecular basis of interactions between antibiotics affecting bacterial cell wall bio-
synthesis and cellular membranes is important in rational drug design of new drugs to overcome resis-
tance. However, a precise understanding of how bacteriostatic antibiotics effect action often neglects the
effect of biophysical forces involved following antibiotic-receptor binding events. We have employed a
combination of a label-free binding biosensor (surface plasmon resonance, SPR) and a force biosensor
(in-plane stress cantilever), together with model membrane systems to study the complex interplay
between glycopeptide antibiotics, their cognate ligands and different model membranes. Bacterial cell
wall precursor analogue N-a-Docosanoyl-e-acetyl-Lys-D-Alanine-D-Alanine (doc-KAA) was inserted into
lipid layers comprised of zwitterionic or anionic lipids then exposed to either vancomycin or the
membrane-anchored glycopeptide antibiotic teicoplanin. Binding afﬁnities and kinetics of the antibiotics
to these model membranes were inﬂuenced by electrostatic interactions with the different lipid back-
grounds, in addition to ligand afﬁnities. In addition, cantilever sensors coated with model membranes
showed that planar surface stress changes were induced by glycopeptide antibiotics adsorption and
caused compressive surface stress generation in a ligand-dependent manner.
 2014 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
The plasma membranes of Gram-positive bacteria are sur-
rounded by a layer of peptidoglycan, which is in the form of a rigid
polymer network, providing structural strength and rigidity to sup-
port the bacteria against lysis [1]. Glycopeptide antibiotics are
active against a wide range of Gram-positive bacteria thanks to
their ability to bind peptidoglycan precursors (lipid II) with termi-
nal sequence -Lys-D-Ala-D-Ala and prevent peptidoglycan synthe-
sis, resulting in bacterial cell lysis [1,2]. Unfortunately, overuse
and misuse of antibiotics has led to the emergence of resistance[3]. Vancomycin is a ‘last resort’ antibiotic against serious infec-
tions caused by Gram positive bacteria. Resistance to vancomycin
is caused by a deceptively simple change of the terminal D-Ala of
the peptidoglycan precursors with D-Lac, resulting in a 1000-fold
decrease in ligand afﬁnity [4]. In order to combat bacterial resis-
tance, extensive efforts have been focused on gaining a deeper
insight of the mode of action of antibiotics by means of studying
the interactions between antimicrobial agents and model mem-
branes [5–7].
Supported lipid membrane models have attracted great atten-
tion as they preserve many biophysical properties of cellular mem-
branes [7]. Particularly, supported lipid bilayers (SLBs) and
supported lipid monolayers (SLMs) have been widely utilized in
combination with optical biosensors to analyze interactions with
many varied membrane–ligand–analyte systems [8]. We have
previously employed bacterial peptidoglycan precursors ana-
logues N-a-Docosanoyl-e-acetyl-Lys-D-Alanine-D-Alanine (doc-KAA)
anchored in the SLMs together with SPR as model membranes to
study the binding interactions between vancomycin group of gly-
copeptide antibiotics and mucopeptide analogue ligands anchored
to lipid surface [9,10]. However, it has been reported that SLBs
formed on an amphipathic polymer cushion (Biacore, L1 chip)
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ions provide a lubricating layer between the surface and the mem-
brane and maintain sufﬁcient mobility for the lipid molecules [11];
(b) they can properly mimic the inherently complex nature of two-
dimensionally ﬂuid plasma membranes and do investigation of
biological processes at the cellular level [12,13] and resist nonspe-
ciﬁc adsorption [8]. Hence, in this study, we have employed doc-
KAA incorporated SLBs as model membranes for binding analysis.
An L1 chip (Fig. 1a) was used and two glycopeptide antibiotics van-
comycin and teicoplanin (Fig. 1c) were tested.
In addition, the cell membranes of Gram-positive bacteria
contain more than one of the phospholipids types, such as
phosphatidylglycerol (PG) with negative charge and zwitterionic
phospholipids phosphatidylcholine (PC) [14]. Charge has previ-
ously been shown to inﬂuence antibiotic activity [15–17]. In this
study, we have explored interactions between model membranes
and antibiotics using SPR.
Cantilever sensors are a unique label free technology in the
sense that they can measure in-plane nanomechanical surface
stress, which is not purely mass dependent [18–20]. When speciﬁc
biochemical interactions occur between a ligand immobilized on
one side of a cantilever and a target analyte in solution, a mechan-
ical bending of the cantilever can occur due to a change in surface
stress [18,19]. Recently, researchers have investigated the use of
cantilever sensors to understand the biophysical forces involved
in drug action [20–25]. Ndieyira and co-workers have reported
the detection of vancomycin binding to bacterial cell wall precur-
sor analogues on cantilever arrays and quantiﬁed binding
constants for vancomycin-sensitive and vancomycin-resistant
mucopeptide analogues [18]. However, this work was carried out
with a rigid, polycrystalline self-assembled monolayer model of
the cell wall mucopeptide. Liu et al. demonstrated that cantilevers
can sense the formation of SLBs on a surface and observe mechan-
ical properties changing of SLBs [19]. In order to gain insight into
the mechanical properties of antibiotic–membrane interactions
and a putative role in cell lysis, we have used cantilever sensors
to observe stress change between glycopeptide antibiotics and
more mimetic model membrane background (Fig. 1b).2. Materials and methods
2.1. Lipid vesicles, ligands-containing vesicles and dye-containing
vesicles preparation
1,2-Dimyristoyl-sn-glycero-3-phosphocholine (DMPC) used for
SPR and cantilevers analysis was purchased from Avanti Polar
Lipids (Australia). 1,2-dimyristoyl-sn-glycero-3-phospho-(10-rac-
glycerol) (DMPG) used for SPR analysis was purchased from Avanti
Polar Lipids (Australia). All the lipids were used as received
without further puriﬁcation. Mucopeptide N-a-Docosanoyl-
e-acetyl-Lys-D-Alanine-D-Alanine (doc-KAA) was synthesized as
described [9,10]. For ﬂuorescent imaging of membranes
formation on cantilevers surface, 1-palmitoyl-2-{6-[(7-nitro-2-1,3-
benzoxadiazol-4-yl)amino]hexanoyl}-sn-glycero-3-phosphocholine
(NBD-C6-PC) was used. Degassed and ﬁltered phosphate buffer
saline (PBS) (100 mM, pH 7.4) was used as the running buffer for
all experiments.
Small unilamellar vesicles (SUVs) were prepared in PBS by
extrusion [26,27]. Brieﬂy, pure or mixed lipids solutions (DMPC
containing 10% doc-KAA w/w, DMPC containing 10% NBD-C6-PC
w/w) were made in ethanol-free chloroform in 10 ml round-bot-
tom ﬂasks, and then deposited as a thin ﬁlm by removal of the sol-
vent (chloroform) under reduced pressure on a rotary evaporator
and dried under high vacuum for at least 2 h. PBS was then added
into each ﬂask to give a suspension, which was sonicated 5 min for5 times. The suspension was passed 17 times through a 50 nm
polycarbonate ﬁlter to produce vesicles. The estimated ﬁnal SUVs
concentration was 0.5 mg/ml.
2.2. Surface plasmon resonance
SPR experiments were carried out with Biacore T200 and Bia-
core 3000 using Biacore L1 biosensor chips (GE Healthcare), which
consisted of modiﬁed carboxymethyl dextran derivatized with
hydrophobic anchors deposited on a gold ﬁlm and contained four
ﬂow cells with a probing spot for the SPR signal. All measurements
were carried out at 25 C.
2.2.1. Loading of L1 sensor chip with SUVs and ligands
SUVs at 0.5 mg/ml concentration were immediately passed
across the surface of the L1 sensor chip for 60 min at a low
ﬂow rate of 2 ll/min, following three 30 s injections of 3-[(3-
cholamidopropyl)dimethylammonio]-2-hydroxy-1-propanesulfonate
(CHAPS, 20 mM) solution at a high ﬂow rate of 30 ll/min to
completely remove the captured lipid bilayers. To remove any
multi-lamellar structures from the lipid surface and to stabilize
the baseline, 10 mM Sodium hydroxide (NaOH) was injected for
1 min at 50 ll/min. The coverage extent of the surface was later
determined by a 5 min injection of bovine serum albumin (BSA,
0.1 mg/ml) at a ﬂow rate of 10 ll/min. The lipid bilayers alone
(control surface) were always in the ﬁrst ﬂow cell of the SPR instru-
ment to prevent contamination from other ﬂow cells containing
ligands. In other ﬂow cells, 0.05 mg/ml doc-kAA solution was then
inserted directly into lipid bilayers across the lipid surface as a
diluted solution at a ﬂow rate of 10 ll/min for 3 min to form
membrane–ligands surface [9].
2.2.2. Glycopeptide antibiotics binding assays
Vancomycin and teicoplanin were purchased from Sigma–
Aldrich (Australia). The antibiotics were serially diluted in running
buffer and then injected sequentially from the lowest (0.1 lM) to
the highest (30 lM) concentration at a ﬂow rate of 20 ll/min for
180 s, followed by a dissociation of 300 s and a 1 min regeneration
with 10 mM Hydrochloric acid (HCl) at a ﬂow rate of 10 ll/min.
The binding assays were performed in triplicate. The normalized
binding responses were corrected by subtraction of the bulk-refrac-
tive index difference and then normalized by dividing the observed
resonance values (RUBound) by the corresponding antibioticmolecu-
lar weight (MW), i.e. 1000  RUBound/MW. Normalization is against
molecular weight because RUBound is mass-dependent [28].
2.3. Cantilever biosensor
Cantilever experiments were carried out with the cantilever
sensor platform instrument CSR-801 (Concentris GmbH, Switzer-
land), which can monitor the absolute bending of arrays of eight
rectangular silicon cantilevers (Concentris GmbH, Switzerland).
The cantilevers are 500 lM in length, 100 lM in width, and 1 lM
thickness, each with a spring constant of 0.026 N/m. The cantile-
vers were coated with 3 nm of titanium followed by a 20 nm gold
layer, resulting in a bimetallic structure. Additionally, the chamber
of CSR-801 was temperature controlled, and for all reported exper-
iments, the chamber was held at 25 C and at a ﬂow rate 0.42 ll/s
for the whole process of experiment.
2.3.1. Cantilever preparation
All cantilever arrays were washed in ultrapure water and
absolute ethanol followed by a UV-ozone (5 min) cleaning cycle
immediately prior to functionalization. Individual cantilevers were
functionalized in parallel by inserting them for 2 h into an array of
liquid-ﬁlled glass capillaries inside the functionalization unit
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Fig. 1. (a) Representation of an SPR measurement and schematic of an SLB immobilized to a surface of the L1 sensor chip. At t = 0 s, buffer ﬂows across tethered SLB surface. At
t = 50 s, a solution of antibiotics in the running buffer is passed over the tethered SLB surface. As the antibiotic binds to the surface, the refractive index of the medium
adjacent to the sensor surface increases, leading to an increase in the resonance signal (35). Analysis of this part of the binding curve gives how fast the antibiotics recognized
with targets. Post injection after t = 230 s, complex is allowed to dissociate. Analysis of this data gives how fast complex apart. (b) Schematic of glycopeptide antibiotics
binding to a SLM coated cantilever in presence of doc-KAA. Adsorption of antibiotics induces a compressive stress on the surface of cantilever and results in cantilever
bending. (c) Structures of glycopeptide antibiotics used in this study: vancomycin and teicoplanin with hydrophobic anchor highlighted in red. At pH = 7.4, vancomycin with
positive charge (+2) and negative charge (); teicoplanin with one positive and negative charge. (For interpretation of the references to color in this ﬁgure legend, the reader
is referred to the web version of this article.)
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on surfaces, the gold surface of cantilevers was passivated with 1-
(9-Mercaptononyl)-3,6,9-trioxaundecan-11-ol (PEG3-SH) (MW =
336.53 Da, Astatech Inc., USA); silicon dioxide surface was coated
with Methoxyl polyethylene glycol silane (mPEG-silane)
(MW = 1000 Da, Life Research Pty Ltd., Australia). Reference
cantilevers were functionalized with both the PEG3-SH and the
mPEG-silane. To form supported membrane on active cantilevers,
they were coated on silicon dioxide surface with mPEG-silane
and functionalized on gold surface with self-assembled monolay-
ers (SAMs) of 1-Hexadecanethiol (HDT) (Sigma–Aldrich, Australia)
as a substrate [29]. HDT-coated cantilevers were washed with
40 mM octyl-D-glucopyranoside (OGP) and ultrapure water clean-
ing cycle and then inserted into the liquid chamber. SUVs solution
(0.5 mg/ml pure DMPC SUVs or 10% doc-KAA-containing or 10%
NBD-C6-PC-containing, 250 ll) was injected in-situ.2.3.2. Quality control experiments on cantilevers
Fluorescence microscopy measurements were performed to
check whether supported membranes formed by vesicles fusion
on HDT-coated cantilevers and cross-check vesicles do not bind
on PEG3-coated reference surface. For vesicle fusion experiments,
cantilever chip containing a cantilever functionalized with a SAM
of HDT, a cantilever coated with PEG3 and a non-functionalizedcantilever were incubated for 10 min with a vesicle solution of
DMPC containing 10% ﬂuorescent lipids (NBD-C6-PC, emission
wavelength 534 nm). Images have been recorded on an inverted
ﬂuorescence microscope.
2.3.3. Cantilever to measure surface stress
To probe how the antibiotic-mucopeptide interactions on sup-
ported lipid layers to generate changes in surface stress, we
selected the cantilever as a stress sensor. The real-time bending
signal of deﬂection at the free end of each cantilever, DZ (nm),
was recorded by CSR-801 system with a sampling frequency of
1 Hz, which was subsequently converted into a differential surface
stress between the front and back sides of the cantilever, Dr (mN/
m) [11], using Stoney’s equation [30] and provided that the case
meets the assumptions in Stoney’s equation [19]:
Dr ¼ 1
3
t
L
 2 E
1 v Dz ð1Þ
where t is the cantilever thickness, L is the cantilever length, E is the
Young’s modulus and m is Poisson’s ratio of the cantilever material.
Prior to the pumping in vesicle solution, the cantilever signals
were set to a zero baseline value. After that, each sample which
consisted of ﬂowing 0.25 mL 10 lM antibiotic solution was
injected, followed by PBS and 10 mM HCl regeneration solution
Va
nc
om
yc
in
Te
ico
pla
nin
0
200
400
600
800
10
00
×R
U
B
ou
nd
/M
W
DMPC
DMPG
DMPC with Doc-KAA
DMPG with Doc-KAA
****
**
****
**
*
**
ns
*
Fig. 3. Histograms showing the normalized response value of glycopeptide
antibiotics at 10 lM bound to DMPC, DMPG in absence/presence of doc-KAA. The
response value has been normalized for the antibiotic molecular weight (MW) as
discussed in Section 2. Statistical comparisons were performed by the unpaired
two-tailed t-test (ns, p > 0.05; ⁄p < 0.05; ⁄⁄p < 0.01; ⁄⁄⁄⁄p < 0.0001). Data are
means ± SD for n = 3.
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known to dissociate antibiotics–peptide complexes and regenerate
the free peptides for further antibiotic studies [9]. The signal differ-
ence between the active cantilever and the reference cantilever
was calculated to allow us to measure the cantilever deﬂection
due to the antibiotic rupture into a supported lipid layer in pres-
ence or absence of ligands. The data were processed using Canti-
sens DataViewer (Concentris GmbH, Switzerland).
3. Results
3.1. Doc-KAA increases the degree of binding of glycopeptide
antibiotics to model membranes
DMPC alone, or Doc-KAA inserted into a DMPC lipid back-
ground, was loaded on an L1 biosensor chip to form fully covered
SLBs [9,10]. The coverage of SLBs was tested by injecting 0.1 mg/
mL BSA solution across the surfaces, and less than 100 RU was
observed, indicating the amphipathic polymer chip surface was
coated with lipid. Vancomycin and teicoplanin were injected indi-
vidually across the SLBs at varying concentrations from 0.1 lM to
30 lM, and RU values were monitored (Fig. 2). Vancomycin
showed a higher binding response to the doc-KAA-DMPC mem-
branes than DMPC only membranes, resulting in 700 RU and
150 RU at 30 lM, respectively. However, lower concentrations
(0.1 lM–1 lM) showed very little binding to both surfaces
(Fig. 2A). In addition, vancomycin completely dissociated from
the DMPC membranes within 1 s after injection; whereas more
than 30% of vancomycin still remained binding to the doc-KAA
membranes 5 min after the injection (Fig. 2A). Teicoplanin showed
a similar binding pattern on doc-KAA-containing DMPC surface as
vancomycin, resulting in 1100 RU at 30 lM. Nevertheless, teicopl-
anin also showed signiﬁcant binding to DMPC membrane, with
700 RU at 30 lM (Fig 2B). At lower concentrations ranging from
0.1 M to 1 lM, teicoplanin bound very weakly to control surface;
while the presence of doc-KAA improved the binding, resulting in
>10% teicoplanin remaining 5 min after the injection (Fig 2B).
3.2. The lipid type affects the binding of glycopeptide antibiotics to
model membranes
Charged lipids have been shown previously to inﬂuence the
way antibiotics interacts with membranes [16,17,31]. WeFig. 2. Sensorgrams for serial 3-fold dilutions of (A) vancomycin (0.1 lM–30 lM) and (B
containing doc-KAA. Antibiotics were injected over 180 s, followed by a dissociation procompared the binding of vancomycin and teicoplanin on model
membranes with different headgroups lipids. Zwitterionic DMPC
and anionic DMPG were chosen for the study, together with the
ligands doc-KAA. Teicoplanin showed a relatively higher afﬁnity
to each model membrane compared to vancomycin (Fig. 3), most
likely due to its pendant C11-acyl side chain motif (Fig. 1c). The
ranking order of binding was the same for both antibiotics:
DMPG/doc-KAA > DMPC/doc-KAA > DMPG > DMPC. The binding
response was signiﬁcantly higher with doc-KAA tethered mem-
branes compared to the surfaces without doc-KAA. In addition,
vancomycin showed more preference for anionic membrane (PG)
over zwitterionic (PC) membrane compared to teicoplanin, regard-
less the presence of Doc-KAA. This may be due to its addition ioni-
sable amino group on the vancosamine residue, which in the case
of teicoplanin is acylated by the C11-acyl chain, resulting in a net
lesser overall positive charge compared to vancomycin. There
was no signiﬁcant difference for teicoplanin binding to DMPC
and DMPG, which supports this hypothesis.
3.3. In-plane surface stresses are induced by binding of glycopeptide
antibiotics to model membranes
The binding interactions exerted mechanical changes were
measured using a cantilever sensor [18]. We have assembled a) teicoplanin (0.1 lM–30 lM), binding to a DMPC bilayer alone; to a DMPC bilayer
cess for another 300 s.
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gold surface of the cantilevers and we generate a hybrid monolayer
by depositing lipid vesicles of DMPC. Hybrid monolayers, or sup-
ported bilayers of DMPC in presence or absence of doc-KAA were
utilized as model membranes. PEG3 coated surface were taken as
a reference surface. Prior to antibiotics (vancomycin, teicoplanin)
analysis, ﬂuorescence microscopy measurements were made as a
quality control method to check whether supported membranes
formed by vesicles fused on HDT-coated cantilevers and verify ves-
icles did not bind on PEG3-coated reference surfaces [32]. When(a) (b)
Fig. 4. Fluorescence microscopy images of: (a) Small unilamellar vesicles (SUVs) compos
same SUVs fused on the SAMs of HDT on cantilevers in situ in the CSR-801 measuremen
CSR-801 measurement chamber.
Fig. 5. Deﬂection measurements upon injection of vancomycin and teicoplanin to (a) su
antibiotic was marked in shade area, and unmarked space was the washing step with bu
teicoplanin (red) and PEG as a reference (purple). Deﬂection was differential bending sig
color in this ﬁgure legend, the reader is referred to the web version of this article.)vesicles composed of DMPC containing 10% ﬂuorescent lipid
NBD-C6-PC were immobilized on the gold surface of the cantilever
chip, intact vesicles could clearly be seen (Fig. 4a). SUVs ﬂowing
across SAMs of HDT, this lipid mixture reorganised from an intact
vesicle layer to the more stable lipid monolayer (Fig. 4b). No ﬂuo-
rescence was observed using vesicles ﬂowing across PEG3 surface
of cantilevers (Fig. 4c).
Downward bending of the cantilevers was observed when the
DMPC SLM was prepared when injecting 10 lM of vancomycin
and teicoplanin (Fig. 5a). We measured a differential bending(c)
ed of DMPC containing 10% NBD-C6-PC loaded on gold surface of cantilevers. (b) The
t chamber. (c) The same SUV fused on the PEG3 surface of cantilevers in situ in the
pported lipid monolayer DMPC and (b) DMPC containing doc-KAA. The injection of
ffer. The ﬂow rate was 0.42/s throughout the whole experiment. Vancomycin (blue),
nals which subtracted PEG reference signal. (For interpretation of the references to
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to 2.4 mN/m and 5.28 mN/m compressive surface stress generation
[19,30]. The same injections were performed on doc-KAA-DMPC
SLM. Injections of both antibiotics on doc-KAA containing surfaces
showed a sharp bending initial response compared to surfaces pre-
senting DMPC alone. Vancomycin induced 20 nm deﬂection
while teicoplanin exerted25 nm (Fig. 5b); values corresponding
to 4.8 mN/m and 6 mN/m compressive surface stress generation,
respectively. Furthermore, after the injections, the signals were
observed to converge back the baseline (zero stress) on DMPC
alone surfaces; while this happened much more slowly with
doc-KAA containing surfaces, consistent with the slower off rate
kinetics observed by SPR.
4. Discussion
In SPR studies, the binding of vancomycin to the control surfaces
was much weaker than that to doc-KAA surfaces, consistent with
previous observations that vancomycin speciﬁcally binds to the
bacterial cell wall precursor lipid II, rather than to phospholipid lay-
ers [9,28,33]. Teicoplanin binds to membranes in the absence of
doc-KAA, due to the lipophilic C11 acyl chain, which can serve as a
membrane anchor to localize the antibiotic in the membrane
[34,35]. The fatty acid chain enhances the lipophilicity of the com-
pound partition coefﬁcient (log P) of teicoplanin (2.26), compared
with vancomycin (4.41) [36]. In the presence of doc-KAA, the
binding of teicoplaninwas also enhanced; attributed to cooperative
binding of precursors analogues binding and membrane anchoring
[10]. This explains why teicoplanin at lower concentrations also
showed signiﬁcant responses, whereas signiﬁcant binding for van-
comycin is only observedwhen concentrations are sufﬁcient to lead
to a dimer population at the membrane surface [33–35,37].
Binding to the anionic membranes or the zwitterionic mem-
branes may correlate with the ability to selectively target bacteria
cells or human cells [15,16]. The weak binding of vancomycin to
zwitterionic membranes (DMPC) and signiﬁcant increased binding
to anionic membranes (DMPG) may result from the electrostatic
interaction of the positively charged (+2) vancomycin with nega-
tively charged PG head groups. In the case of teicoplanin, which
contains only one positive charge, little difference was observed
between the binding to DMPC and DMPG, indicating the binding
of teicoplanin to membrane models primarily attributes to mem-
brane anchoring driven by hydrophobic interactions, rather than
electrostatic interactions. This is consistent with a previous study
that reported the afﬁnities calculated using the different types of
lipid were very similar for antibiotics bound in a biphasic manner
such as strongly dimerizing and lipid-anchoring [10]. In the pres-
ence of both doc-KAA and DMPG, enhanced binding of vancomycin
was observed (Fig. 3, ⁄⁄p < 0.01). This may due to the combined
effect of electrostatic interaction and precursors analogues bind-
ing. Teicoplanin showed signiﬁcant binding on anionic membranes
compared to zwitterionic membranes in presence of doc-KAA
(Fig. 3, ⁄p < 0.05), probably owing to synergistic effects of precur-
sors analogues binding, membrane anchoring and electrostatic
interaction.
Cantilever sensors gave valuable insights into the mechanical
nature of antibiotic–membrane–ligand interactions from a bio-
physical perspective. In cantilever sensing studies, hybrid mono-
layers with ligands were applied as model membranes. It is
considered that the method of formation SLBs on L1 chip in SPR
studies is unsuited for the cantilever experiment, as it is hard to
form stable SLBs on cantilever in bending status owing to its ﬂex-
ible and considerable vertical motion [8]. Cantilevers measure-
ments shown in Fig. 5a demonstrated that vancomycin and
teicoplanin bound in DMPC membrane could induce a compressive
change in surface stress, with stronger stress generation for tei-coplanin. This trend was consistent with the above SPR studies. It
may result from the adsorption of the antibiotics at close proximity
to the lipids, causing expansion of the lipid surface, thus expanding
the layer and inducing the downward bending. Stronger bending
for teicoplanin might derive from its lipophilic tail insertion, which
may cause rearrangement of the phospholipids in the membrane
and resulting in a more crowded surface.
In presence of doc-KAA, both antibiotics showed a steeper initial
change of downward bending andmaintained a very slow reversion
to baseline post injection. When compared with the results we
obtained on SPR, we can observe that dissociation of the com-
pounds, which occurs in the time scale of the cantilever experiment,
does not result in correspondent relaxation of the surface to the ori-
ginal conﬁguration. This suggests that some of the interactions
induced by antibiotic action on the membrane may occur on a dif-
ferent time scale than simple antibiotic-ligand binding interactions.
In addition, vancomycin exhibited an increased compressive stress
when binding on the doc-KAA modiﬁed surface, well correlating
with the results obtained on SPR. However, the measured surface
stress is relatively weak when compared to the previous literature,
where binding of vancomycin to a polycrystalline self-assembled
monolayer of KAA was tested [18]. It is plausible that addition of
a lipid membrane is capable of partially dissipating the induced
stress [38], which would not be possible in a high shear-modulus
SAM surface. The local rearrangement induced by the binding with
the glycopeptide antibiotics is therefore partially dissipated by the
viscoelastic response of the lipid layer and only partially transferred
to the cantilever, resulting in reduced compressive surface stress
compared to the SAM surface. The mild increase in binding afﬁnity
observed in SPR for teicoplanin did not translate in signiﬁcant stress
change in presence of doc-KAA, which raises the question as to the
role of surface dimerization in the generation of in-plane stresses,
an issue beyond the scope of this paper.
In summary, we have shown that the bacterial cell wall precur-
sor analogue doc-KAA enhanced glycopeptide antibiotic binding
using SLBs as model membranes, which more closely resembled
cellular membrane than prior work using SAMs. Moreover, it dem-
onstrated that electrostatic interactions may play a role in the
mode of action of vancomycin, but not for teicoplanin. Hybrid
monolayers with doc-KAA coating on cantilever arrays could be
useful to further understand the role of ‘‘stress’’ in antibiotic action,
which may have a role to play in weakening the bacterial cell
membrane. Future research should address electrostatic interac-
tions and ﬂuidity of the biomimetic membranes with variant tem-
perature, conductivity and ionic strength conditions.
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